Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of an ER stress-related prognostic signature for predicting prognosis and screening the effective anti-tumor drug in osteosarcoma. | J Transl Med | 2024 | 38229155 | PubTator, text mining | PubMed |
| Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis. | Comput Struct Biotechnol J | 2024 | 38226313 | PubTator, text mining | PubMed |
| Multipronged regulation of autophagy and apoptosis: emerging role of TRIM proteins. | Cell Mol Biol Lett | 2024 | 38225560 | PubTator, text mining | PubMed |
| Cancer vaccines: from an immunology perspective. | Immunother Adv | 2024 | 38223410 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of human pleura reveals stromal heterogeneity and informs in vitro models of mesothelioma. | Eur Respir J | 2024 | 38212075 | PubTator, text mining | PubMed |
| Vaccines: a promising therapy for myelodysplastic syndrome. | J Hematol Oncol | 2024 | 38191498 | PubTator, text mining | PubMed |
| Historical perspective and future directions: computational science in immuno-oncology. | J Immunother Cancer | 2024 | 38191244 | PubTator, text mining | PubMed |
| High production MBL2 polymorphisms protect against COVID-19 complications in critically ill patients: A retrospective cohort study. | Heliyon | 2024 | 38187242 | PubTator, text mining | PubMed |
| FTHL17, PRM2, CABYR, CPXCR1, ADAM29, and CABS1 are highly expressed in colon cancer patients and are regulated in vitro by epigenetic alterations. | Heliyon | 2024 | 38187237 | PubTator, text mining | PubMed |
| MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer. | Aging (Albany NY) | 2024 | 38180746 | PubTator, text mining | PubMed |
| Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape. | Theranostics | 2024 | 38169577 | PubTator, text mining | PubMed |
| Path towards mRNA delivery for cancer immunotherapy from bench to bedside. | Theranostics | 2024 | 38164145 | PubTator, text mining | PubMed |
| Wilms' tumor 1 -targeting cancer vaccine: Recent advancements and future perspectives. | Hum Vaccin Immunother | 2024 | 38148629 | PubTator, text mining | PubMed |
| ELM-the Eukaryotic Linear Motif resource-2024 update. | Nucleic Acids Res | 2024 | 37962385 | PubTator, text mining | PubMed |
| Self-assembled peptide/polymer hybrid nanoplatform for cancer immunostimulating therapies. | Drug Deliv Transl Res | 2024 | 37721693 | PubTator, text mining | PubMed |
| Bioinformatics-based analysis of programmed cell death pathway and key prognostic genes in gastric cancer: Implications for the development of therapeutics. | J Gene Med | 2024 | 37670467 | PubTator, text mining | PubMed |
| Bioprinting extracellular vesicles as a "cell-free" regenerative medicine approach. | Extracell Vesicles Circ Nucl Acids | 2023 | 39697984 | PubTator, text mining | PubMed |
| Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune Response. | Curr Oncol | 2023 | 38275827 | PubTator, text mining | PubMed |
| Harnessing Immunity to Treat Advanced Thyroid Cancer. | Vaccines (Basel) | 2023 | 38250858 | PubTator, text mining | PubMed |
| Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox. | Curr Oncol | 2023 | 38248092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=5